首页> 外文OA文献 >Carbonic Anhydrase Inhibitors. Part 91. Metal Complexes of Heterocyclic Sulfonamides as Potential Pharmacological Agents in the Treatment of Gastric Acid Secretion Imbalances
【2h】

Carbonic Anhydrase Inhibitors. Part 91. Metal Complexes of Heterocyclic Sulfonamides as Potential Pharmacological Agents in the Treatment of Gastric Acid Secretion Imbalances

机译:碳酸酐酶抑制剂。第91部分。杂环磺酰胺的金属配合物作为治疗胃酸分泌失衡的潜在药理剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Zinc, magnesium, aluminum and copper complexes of several potent, clinically used carbonic anhydrase (CA) sulfonamide inhibitors, such as acetazolamide, methazolamide, ethoxzolamide and benzolamide were tested for their possible applications as antacids, in experimental animals. Gastric acid secretion parameters 3 days after treatment with these CA inhibitors (2 × 500 mg, twice a day), in dogs with chronic gastric fistulas, led to the observation that the gastric acid parameters BAO (the basal acid output), and MAO (the maximal acid output after stimulation with histamine) were drastically reduced, as compared to the same parameters in animals that did not receive these enzyme inhibitors. These are promising results for the possible use of metal complexes of heterocyclic sulfonamides as treatment alternatives (alone or in combination with other drugs) for gastric acid secretion imbalances.
机译:测试了几种有效的临床使用的碳酸酐酶(CA)磺酰胺抑制剂(如乙唑酰胺,甲唑酰胺,乙氧乙酰胺和苯甲酰胺)作为抗酸剂的锌,镁,铝和铜络合物在实验动物中的可能用途。在患有慢性胃瘘的犬中,使用这些CA抑制剂(2×500 mg,每天两次)治疗3天后的胃酸分泌参数导致观察到胃酸参数BAO(基础酸输出)和MAO(与未接受这些酶抑制剂的动物中的相同参数相比,组胺刺激后的最大酸输出量显着降低。对于将杂环磺酰胺的金属络合物用作胃酸分泌失衡的治疗替代方案(单独或与其他药物组合),这些结果令人鼓舞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号